ES2843511T3 - Métodos para reducir las concentraciones en sangre de triglicéridos, colesterol total y lipoproteínas de baja densidad - Google Patents
Métodos para reducir las concentraciones en sangre de triglicéridos, colesterol total y lipoproteínas de baja densidad Download PDFInfo
- Publication number
- ES2843511T3 ES2843511T3 ES14829314T ES14829314T ES2843511T3 ES 2843511 T3 ES2843511 T3 ES 2843511T3 ES 14829314 T ES14829314 T ES 14829314T ES 14829314 T ES14829314 T ES 14829314T ES 2843511 T3 ES2843511 T3 ES 2843511T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- metabolite
- formula
- ester
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CCc(c(SI(C)*c1ccc(C(C)O)c(**)c1C)ccc1*)c1O Chemical compound CCc(c(SI(C)*c1ccc(C(C)O)c(**)c1C)ccc1*)c1O 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361858450P | 2013-07-25 | 2013-07-25 | |
| PCT/US2014/047797 WO2015013395A1 (en) | 2013-07-25 | 2014-07-23 | Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2843511T3 true ES2843511T3 (es) | 2021-07-19 |
Family
ID=52391020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14829314T Active ES2843511T3 (es) | 2013-07-25 | 2014-07-23 | Métodos para reducir las concentraciones en sangre de triglicéridos, colesterol total y lipoproteínas de baja densidad |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20150031769A1 (enExample) |
| EP (1) | EP3024454B1 (enExample) |
| JP (1) | JP6363192B2 (enExample) |
| KR (1) | KR102352728B1 (enExample) |
| CN (1) | CN105407884B (enExample) |
| BR (1) | BR112016001400B1 (enExample) |
| CA (1) | CA2917780C (enExample) |
| ES (1) | ES2843511T3 (enExample) |
| WO (1) | WO2015013395A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024522030A (ja) | 2021-05-28 | 2024-06-10 | メディシノバ・インコーポレイテッド | フェノキシアルキルカルボン酸誘導体、およびトリグリセリドレベルを低下させることにおけるその使用 |
| WO2024117173A1 (ja) | 2022-11-30 | 2024-06-06 | 花王株式会社 | 痒みの予防又は改善剤 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2585246A1 (fr) | 1985-07-26 | 1987-01-30 | Cortial | Procede d'obtention de formes pharmaceutiques solides a liberation prolongee |
| US4788055A (en) | 1985-12-09 | 1988-11-29 | Ciba-Geigy Corporation | Resinate sustained release dextromethorphan composition |
| GB8613688D0 (en) | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| GB8613689D0 (en) | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| US4816264A (en) | 1986-06-06 | 1989-03-28 | Warner-Lambert Company | Sustained release formulations |
| US4985585A (en) | 1988-03-07 | 1991-01-15 | Kyorin Pharmaceutical Co., Ltd. | Phenoxyalkylcarboxylic acid derivatives and process for their preparations |
| US4996047A (en) | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
| CA2002492A1 (en) | 1988-11-11 | 1990-05-11 | Sandra T. A. Malkowska | Pharmaceutical ion exchange resin composition |
| US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5290812A (en) | 1991-01-18 | 1994-03-01 | Kyorin Pharmaceutical Co., Ltd. | Phenoxyalkylcarboxylic acid derivatives and process of preparing the same |
| US7060854B2 (en) | 2003-06-24 | 2006-06-13 | Medicinova, Inc. | Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid |
| US7064146B2 (en) | 2003-06-24 | 2006-06-20 | Medicinova, Inc. | Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use |
| KR20070058381A (ko) * | 2004-04-27 | 2007-06-08 | 메디시노바, 인크. | 염증성 질환 치료용 페녹시알킬카르복실 산 유도체 |
| AU2005259864A1 (en) * | 2004-06-30 | 2006-01-12 | Combinatorx, Incorporated | Methods and reagents for the treatment of metabolic disorders |
| CN101193656B (zh) * | 2005-06-08 | 2011-03-02 | 兴和株式会社 | 甘油三酸酯降低剂 |
| WO2009002746A1 (en) * | 2007-06-22 | 2008-12-31 | Decode Genetics Ehf. | Dosing schedules of leukotriene synthesis inhibitors for human therapy |
-
2014
- 2014-07-23 CA CA2917780A patent/CA2917780C/en active Active
- 2014-07-23 EP EP14829314.5A patent/EP3024454B1/en active Active
- 2014-07-23 CN CN201480041441.4A patent/CN105407884B/zh active Active
- 2014-07-23 WO PCT/US2014/047797 patent/WO2015013395A1/en not_active Ceased
- 2014-07-23 JP JP2016529856A patent/JP6363192B2/ja active Active
- 2014-07-23 KR KR1020167002772A patent/KR102352728B1/ko active Active
- 2014-07-23 ES ES14829314T patent/ES2843511T3/es active Active
- 2014-07-23 BR BR112016001400-6A patent/BR112016001400B1/pt active IP Right Grant
- 2014-07-23 US US14/339,331 patent/US20150031769A1/en not_active Abandoned
- 2014-11-13 US US14/540,766 patent/US9358217B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2917780C (en) | 2023-01-24 |
| EP3024454A1 (en) | 2016-06-01 |
| BR112016001400A8 (pt) | 2020-01-14 |
| EP3024454A4 (en) | 2017-03-15 |
| WO2015013395A1 (en) | 2015-01-29 |
| KR102352728B1 (ko) | 2022-01-18 |
| US20150080471A1 (en) | 2015-03-19 |
| US20150031769A1 (en) | 2015-01-29 |
| CN105407884A (zh) | 2016-03-16 |
| EP3024454B1 (en) | 2020-10-21 |
| CA2917780A1 (en) | 2015-01-29 |
| BR112016001400A2 (pt) | 2017-07-25 |
| CN105407884B (zh) | 2019-04-30 |
| KR20160034324A (ko) | 2016-03-29 |
| JP6363192B2 (ja) | 2018-07-25 |
| BR112016001400B1 (pt) | 2023-02-28 |
| US9358217B2 (en) | 2016-06-07 |
| JP2016525546A (ja) | 2016-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6608404B2 (ja) | 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の処置方法 | |
| HUE027711T2 (en) | An aqueous formulation of improved stability of (E) -4-carboxystyril-4-chlorobenzylsulfone | |
| ES2843511T3 (es) | Métodos para reducir las concentraciones en sangre de triglicéridos, colesterol total y lipoproteínas de baja densidad | |
| JP2022501390A (ja) | 化合物及びその用途 | |
| TW201929846A (zh) | 包含苯基磺醯胺之醫藥組合物及其治療應用 | |
| US9498458B2 (en) | Method of inhibiting or treating fibrosis | |
| JP2025530781A (ja) | 新規のイオン化可能な脂質および脂質ナノ粒子ならびにそれらの使用方法 | |
| TW201625543A (zh) | 羥吡啶酮衍生物，其醫藥組合物，及其用於發炎性、神經退化性或免疫媒介疾病之治療用途 | |
| CA3217719A1 (en) | Phenoxyalkylcarboxylic acid derivatives and their use in lowering triglyceride levels | |
| US20150320705A1 (en) | Method of inhibiting or treating amyotrophic lateral sclerosis with phenoxyalkylcarboxylic acids | |
| BR112019011789B1 (pt) | Compostos de quinona e ácido ascórbico para tratar doença de chagas |